Showing 5111-5120 of 8784 results for "".
- AAD/NPF Guidelines Address Pediatric PsOhttps://practicaldermatology.com/news/aadnpf-guidelines-address-pediatric-pso/2460234/New guidelines from the American Academy of Dermatology and the National Psoriasis Foundation offer counsel on how to best manage psoriasis and its extracutaneous manifestations in children and adolescents. The 2019 guidelines of care for the management and treatment of psoriasis i
- Daavlin, HealthLens Partner to Increase Phototherapy Accesshttps://practicaldermatology.com/news/daavlin-healthlens-partner-to-increase-phototherapy-access/2460232/Daavlin, a leading U.S. manufacturer of phototherapy units, is teaming up with HealthLens to increase access to phototherapy via teledermatology. Appointment wait times for dermatology services have increased by 46 percent since 2009, according to
- Proscia and Johns Hopkins School of Medicine Collaborate to Bring AI Applications to High-Impact Diseases and Specialties in Pathologyhttps://practicaldermatology.com/news/proscia-and-johns-hopkins-school-of-medicine-collaborate-to-bring-ai-applications-to-high-impact-diseases-and-specialties-in-pathology/2460231/Proscia, a provider of AI-enabled digital pathology software, and Johns Hopkins School of Medicine, one of the leading academic medical centers in the US, will collaborate on the development of computational applications that incorporate artificial intelligence (AI) to advance the practice of pat
- Lutronic's New Thulium Laser is Most Powerful to be FDA Clearedhttps://practicaldermatology.com/news/lutronics-new-thulium-laser-is-most-powerful-to-be-fda-cleared/2460230/Lutronic unveiled the new LaseMD ULTRA™ during live patient demonstrations at the Cosmetic Surgery Forum in Nashville, TN. The LaseMD ULTRA offersthe highest available power that allows for fast treatments, customizable for multiple areas. Additionally, the system providesgen
- Cutera Rolls Out Heroes Among Us Programhttps://practicaldermatology.com/news/cutera-rolls-out-heroes-among-us-program/2460228/Cutera is launching its new “Heroes Among Us” program to showcase patients who’ve been positively affected by Cutera technologies. The new program was launched at the Cutera University Clinical Forum (CUCF) in Scott
- Norfolk Dermatologist Recognized for Increasing Accessibility for Patientshttps://practicaldermatology.com/news/norfolk-dermatologist-recognized-for-increasing-accessibility-for-patients/2460227/Dermatologist Abby Van Voorhees, MD, FAAD, is an American Academy of Dermatology Patient Care Hero for her leadership at the Rapid Access Clinic at the Eastern Virginia Medical School Dermatology Practice in Norfolk, Va. The Eastern Virginia Medical School Dermatology practice allo
- NavaDerm Partners Adds Dan Wechsler as Executive Chairmanhttps://practicaldermatology.com/news/navaderm-partners-adds-dan-wechsler-as-executive-chairman/2460225/Dan Wechsler is the new Executive Chairman of NavaDerm Partners, a Northeast-focused dermatology services company and portfolio company of BelHealth Investment Partners, a New York-based healthcare private equity firm. Wechs
- Baring Private Equity Asia Agrees to Acquire Lumenishttps://practicaldermatology.com/news/baring-private-equity-asia-agrees-to-acquire-lumenis-1/2460222/Baring Private Equity Asia’s affiliated private equity funds are acquiring Lumenis. The transaction, which values Lumenis at an enterprise value of more than $1 billion, remains subject to the customary regulatory approval process. It is expected to be completed in early 2020. <
- Dermatologists Issue Guidelines for Opioid Management Following 87 Common Procedureshttps://practicaldermatology.com/news/dermatologists-issue-guidelines-for-opioid-management-following-87-common-procedures/2460219/New dermatologic procedure-recommendations for opioid management seek to help curtail the opioid epidemic and reduce the number of opioid overdose deaths. The new consensus statement was developed by a group of 40 board-certified dermatologists, including Mohs micrographic surgeons, der
- Allergan Pays Exicure $25M upfront in Collaboration Deal to Develop Hair Loss Treatmenthttps://practicaldermatology.com/news/allergan-pays-exicure-25m-upfront-in-collaboration-deal-to-develop-hair-loss-treatment/2460216/Allergan Pharmaceuticals International Limited has entered into a global collaboration agreement with Exicure to discover and develop novel treatments for hair loss disorders based on Exicure’s proprietary SNA technology. Allergan will receive exclusive access and options to licen